|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007097,
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0013089,
umls-concept:C0016360,
umls-concept:C0025677,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0042670,
umls-concept:C0061008,
umls-concept:C0205179,
umls-concept:C0205390
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-7-21
|
|
pubmed:abstractText |
A phase II randomized trial of gallium nitrate/fluorouracil (5-FU) versus dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) was performed in poor-risk patients with advanced urothelial tract tumors. The efficacy and toxicity of these regimens were compared. Assessment of dose-intense M-VAC as salvage treatment in patients who failed to respond to the gallium nitrate/5-FU regimen was also performed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2449-55
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9196161-Adult,
pubmed-meshheading:9196161-Aged,
pubmed-meshheading:9196161-Aged, 80 and over,
pubmed-meshheading:9196161-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9196161-Carcinoma, Transitional Cell,
pubmed-meshheading:9196161-Cisplatin,
pubmed-meshheading:9196161-Doxorubicin,
pubmed-meshheading:9196161-Female,
pubmed-meshheading:9196161-Fluorouracil,
pubmed-meshheading:9196161-Gallium,
pubmed-meshheading:9196161-Humans,
pubmed-meshheading:9196161-Male,
pubmed-meshheading:9196161-Methotrexate,
pubmed-meshheading:9196161-Middle Aged,
pubmed-meshheading:9196161-Survival Analysis,
pubmed-meshheading:9196161-Treatment Outcome,
pubmed-meshheading:9196161-Urologic Neoplasms,
pubmed-meshheading:9196161-Vinblastine
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
